Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia.
Carisma Therapeutics Inc. today reported financial results for the fourth quarter, and full year ended December 31, 2023, and provided a business update.
The new company includes 3M’s medical, dental, health IT and filtration products.
The company has developed a virtual reality surgical platform for training and assessment.
Osso VR to lay off 67 people at corporate headquarters Read More »
AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the fourth quarter and full year ended December 31, 2023.
AquaBounty Technologies Announces Fourth Quarter and Full Year 2023 Financial Results Read More »
Aculys Pharma, Inc. announces the appointment of Hidemasa Tanigaki as Chief Executive Officer and Representative Director, effective March 29th.
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO Read More »
3M completed the planned spin-off of its health care business, which formally launches Solventum Corporation as an independent company.
Foresee Pharmaceuticals, announces the positive safety review by the independent Data and Safety Monitoring Board for its Casppian Phase 3 registration study.
Avery Dennison Corporation will host its first quarter 2024 earnings conference call in a live webcast at 12:00 p.m. ET on Wednesday, April 24, 2024.
Avery Dennison to Webcast First Quarter 2024 Earnings Conference Call Read More »
Merck, known as MSD outside of the United States and Canada, will hold its first-quarter 2024 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, April 25.
Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25 Read More »
